Antibiotic Prophylaxis for the Prevention of Urinary Tract Infections in Children: Guideline and Recommendations from the Emilia-Romagna Pediatric Urinary Tract Infections (UTI-Ped-ER) Study Group

Urinary tract infection (UTI) represents one of the most common infectious diseases and a major cause of antibiotic prescription in children. To prevent recurrent infections and long-term complications, low-dose continuous antibiotic prophylaxis (CAP) has been used. However, the efficacy of CAP is c...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) Vol. 12; no. 6; p. 1040
Main Authors: Autore, Giovanni, Bernardi, Luca, Ghidini, Filippo, La Scola, Claudio, Berardi, Alberto, Biasucci, Giacomo, Marchetti, Federico, Pasini, Andrea, Capra, Maria Elena, Castellini, Claudia, Cioni, Vera, Cantatore, Sante, Cella, Andrea, Cusenza, Francesca, De Fanti, Alessandro, Della Casa Muttini, Elisa, Di Costanzo, Margherita, Dozza, Alessandra, Gatti, Claudia, Malaventura, Cristina, Pierantoni, Luca, Parente, Giovanni, Pelusi, Gabriella, Perrone, Serafina, Serra, Laura, Torcetta, Francesco, Valletta, Enrico, Vergine, Gianluca, Antodaro, Francesco, Bergomi, Andrea, Chiarlolanza, Jennifer, Leoni, Laura, Mazzini, Franco, Sacchetti, Roberto, Suppiej, Agnese, Iughetti, Lorenzo, Pession, Andrea, Lima, Mario, Esposito, Susanna, The Uti-Ped-Er Study Group
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 01-06-2023
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Urinary tract infection (UTI) represents one of the most common infectious diseases and a major cause of antibiotic prescription in children. To prevent recurrent infections and long-term complications, low-dose continuous antibiotic prophylaxis (CAP) has been used. However, the efficacy of CAP is controversial. The aim of this document was to develop updated guidelines on the efficacy and safety of CAP to prevent pediatric UTIs. A panel of experts on pediatric infectious diseases, pediatric nephrology, pediatric urology, and primary care was asked clinical questions concerning the role of CAP in preventing UTIs in children. Overall, 15 clinical questions were addressed, and the search strategy included accessing electronic databases and a manual search of gray literature published in the last 25 years. After data extraction and narrative synthesis of results, recommendations were developed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) methodology. The use of CAP is not recommended in children with a previous UTI, with recurrent UTIs, with vesicoureteral reflux (VUR) of any grade, with isolated hydronephrosis, and with neurogenic bladder. CAP is suggested in children with significant obstructive uropathies until surgical correction. Close surveillance based on early diagnosis of UTI episodes and prompt antibiotic therapy is proposed for conditions in which CAP is not recommended. Our systematic review shows that CAP plays a limited role in preventing recurrences of UTI in children and has no effect on its complications. On the other hand, the emergence of new antimicrobial resistances is a proven risk.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Membership of the UTI-Ped-ER Study Group is provided in the Acknowledgment.
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics12061040